These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17646422)

  • 1. Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis.
    Castagnola E; Cappelli B; Faraci M; Fallani S; Cassetta MI; Novelli A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3775. PubMed ID: 17646422
    [No Abstract]   [Full Text] [Related]  

  • 2. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
    Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
    Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction.
    van der Elst KC; Brüggemann RJ; Rodgers MG; Alffenaar JW
    Transpl Infect Dis; 2012 Aug; 14(4):440-3. PubMed ID: 22316392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
    Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
    J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
    Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P
    Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
    Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
    Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
    Herbrecht R; Maertens J; Baila L; Aoun M; Heinz W; Martino R; Schwartz S; Ullmann AJ; Meert L; Paesmans M; Marchetti O; Akan H; Ameye L; Shivaprakash M; Viscoli C
    Bone Marrow Transplant; 2010 Jul; 45(7):1227-33. PubMed ID: 20062093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.
    Hiemenz JW; Raad II; Maertens JA; Hachem RY; Saah AJ; Sable CA; Chodakewitz JA; Severino ME; Saddier P; Berman RS; Ryan DM; Dinubile MJ; Patterson TF; Denning DW; Walsh TJ
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1387-94. PubMed ID: 20703506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micafungin use in children.
    Emiroglu M
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin: new indication. Same indications in children as in adults.
    Prescrire Int; 2009 Aug; 18(102):155. PubMed ID: 19743569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II dose escalation study of caspofungin for invasive Aspergillosis.
    Cornely OA; Vehreschild JJ; Vehreschild MJ; Würthwein G; Arenz D; Schwartz S; Heussel CP; Silling G; Mahne M; Franklin J; Harnischmacher U; Wilkens A; Farowski F; Karthaus M; Lehrnbecher T; Ullmann AJ; Hallek M; Groll AH
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5798-803. PubMed ID: 21911573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.
    Spriet I; Meersseman W; Annaert P; de Hoon J; Willems L
    Eur J Clin Pharmacol; 2011 Jul; 67(7):753-5. PubMed ID: 21638033
    [No Abstract]   [Full Text] [Related]  

  • 16. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
    Pagano L; Caira M; Candoni A; Offidani M; Martino B; Specchia G; Pastore D; Stanzani M; Cattaneo C; Fanci R; Caramatti C; Rossini F; Luppi M; Potenza L; Ferrara F; Mitra ME; Fadda RM; Invernizzi R; Aloisi T; Picardi M; Bonini A; Vacca A; Chierichini A; Melillo L; de Waure C; Fianchi L; Riva M; Leone G; Aversa F; Nosari A
    Haematologica; 2010 Apr; 95(4):644-50. PubMed ID: 19850903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis.
    Mori M; Imaizumi M; Ishiwada N; Kaneko T; Goto H; Kato K; Hara J; Kosaka Y; Koike K; Kawamoto H; Maeda N; Yoshinari T; Kishino H; Takahashi K; Kawahara S; Kartsonis NA; Komada Y
    J Infect Chemother; 2015 Jun; 21(6):421-6. PubMed ID: 25701307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
    Kerl K; Koch B; Fegeler W; Rossig C; Ehlert K; Groll AH
    Transpl Infect Dis; 2011 Apr; 13(2):182-5. PubMed ID: 20738831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of therapeutic concentrations of micafungin administered 5 days/week in a leukemic adolescent with invasive candidiasis.
    Castagnola E; Cangemi G; Barco S; Bandettini R; Dallorso S; Virga F; Dufour C
    Clin Microbiol Infect; 2014 Nov; 20(11):O975-6. PubMed ID: 24621154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.